Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 992
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2001  |  Volume : 49  |  Issue : 2  |  Page : 91-95

Assessing the role of subconjunctival versus intrascleral application of Mitomycin-C in high-risk trabeculectomies


Glaucoma Service, Dr. R.P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India

Correspondence Address:
Harish C Agarwal
Glaucoma Service, Dr. R.P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 15884512

Rights and PermissionsRights and Permissions

Purpose: To compare the efficacy and safety of subconjunctival and intrascleral applications of mitomycin C (MMC) in trabeculectomy for high-risk glaucomas. Methodology: A randomized prospective clinical study was conducted on 41 consecutive eyes with a high risk of glaucoma surgery failure. Patients were randomized to trabeculectomy and application of subconjunctival MMC or to trabeculectomy and application of intrascleral MMC. MMC solution 0.2 mg/ml was applied for 3 minutes under the conjunctival flap overlying the proposed site of trabeculectomy in Group 1 (n=21), or intrasclerally under the superficial scleral flap in Group II (n=20) Results: After a follow-up of one year, the intraocular pressure (IOP) decreased from a mean basal IOP of 33.0 8.4 mm Hg to 12.56 2.54 mm Hg in Group I and from 30.9 6.6 mm Hg to 11.6 2.21 mm Hg in Group II. The IOP was 6 - 21 mmHg, without medication, in 90.5 % of the eyes in Group I and 75 % of the eyes Group II. Ocular hypotony, hypotony maculopathy, choroidal detachment and a shallow anterior chamber were more frequent with the intrascleral application of MMC during trabeculectomy, but the difference was not statistically significant. The overall success of the surgery at one year, i.e., achieving an IOP of 6 - 21 mmHg and a stable vision, (reduction in visual acuity of ≤2 lines), was 90.5% in Group I and 75 % in Group II. Conclusion: No significant difference was seen in overall success or complication between subconjunctival and intrascleral application of MMC-augmented trabeculectomies in glaucomatous eyes at high risk of surgical failure.


[FULL TEXT] [PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3195    
    Printed153    
    Emailed5    
    PDF Downloaded24    
    Comments [Add]    
    Cited by others 2    

Recommend this journal